NCT00166296 Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients Status COMPLETED Phase PHASE2
NCT00157547 Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression Status COMPLETED Phase PHASE4
NCT00149825 Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome Status COMPLETED Phase PHASE2
NCT00146523 An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression Status COMPLETED Phase PHASE3
NCT00135421 Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder Status COMPLETED Phase PHASE1/PHASE2
NCT00130676 A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression Status COMPLETED Phase PHASE3
NCT00128505 An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression Status COMPLETED Phase PHASE3
NCT00128479 A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression Status COMPLETED Phase PHASE3
NCT00125957 The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression Status COMPLETED Phase PHASE3
NCT00109044 Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00108979 Study of Escitalopram in Adult Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00108407 Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse Status COMPLETED Phase NA
NCT00107120 The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00105196 A Study of Aripiprazole in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00104611 Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00095823 A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3